| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | — | +44.3% |
| Cost of Revenue | $5.5M | — | +79.1% |
| Gross Profit | -$495K | — | -226.6% |
| R&D Expense | $234K | — | -49.4% |
| SG&A Expense | $1.7M | — | +17.1% |
| Operating Income | -$2.9M | — | -10.7% |
| Pre-tax Income | -$2.9M | — | -10.1% |
| Income Tax | $0 | — | — |
| Net Income | -$2.9M | — | -10.1% |
| EPS (Basic) | -$0.06 | — | -131.9% |
| EPS (Diluted) | -$0.06 | — | -131.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $240K | -76.7% | — |
| Accounts Receivable | $3.9M | +9.6% | +2.8% |
| Inventory | $6.1M | -1.9% | +159.1% |
| Current Assets | $12.6M | +1.8% | +46.7% |
| Total Assets | $30.8M | +50.6% | +86.7% |
| Current Liabilities | $8.3M | +13.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | -38.7% |
| Investing Cash Flow | -$211K | — | -41.3% |
| Financing Cash Flow | $818K | — | -74.0% |
| -24.7% |
| Total Liabilities | $12.3M | +7.9% | -1.9% |
| Stockholders' Equity | $18.4M | +104.8% | +371.8% |